Sign Up to like & get
recommendations!
0
Published in 2022 at "Clinical and Translational Allergy"
DOI: 10.1002/clt2.12092
Abstract: Abstract Background Hereditary angioedema (HAE), a rare disease that is characterized by painful and recurring non‐allergic swelling episodes, is caused by the deficiency or dysfunction of C1 inhibitor (C1INH) protein. A comprehensive HAE management plan…
read more here.
Keywords:
hae;
hereditary angioedema;
clinical considerations;
guideline recommendations ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2023 at "Clinical and Translational Allergy"
DOI: 10.1002/clt2.12243
Abstract: Abstract Patients with hereditary angioedema (HAE) experience a high burden of disease due to unpredictable, painful, disfiguring, and potentially life‐threatening HAE attacks. Multiple HAE‐specific medications for the on‐demand treatment, short‐term and long‐term prophylaxis of HAE…
read more here.
Keywords:
hae;
hereditary angioedema;
hae management;
challenges future ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Immunology"
DOI: 10.1007/s10875-018-0553-4
Abstract: PurposeHereditary angioedema (HAE) is a rare disease caused by a C1 inhibitor (C1-INH) deficit. Clinically, HAE is manifested by repeated episodes of localized subcutaneous or submucosal oedema attacks. Managing HAE patients in pregnancy is challenging,…
read more here.
Keywords:
inh;
pregnancy;
inhibitor;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Dermatology and Therapy"
DOI: 10.1007/s13555-021-00593-x
Abstract: The goal of this article is to discuss the importance of differentiating hereditary angioedema (HAE) from other types of angioedema, describe advances in HAE management, especially long-term prophylaxis (LTP), and offer practical recommendations for dermatologists.…
read more here.
Keywords:
management;
hereditary angioedema;
management hereditary;
recognition management ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Clinical biochemistry"
DOI: 10.1016/j.clinbiochem.2017.04.007
Abstract: OBJECTIVES Low complement factor C4 is usually considered a valuable screening tool for patients with the potentially life-threatening hereditary angioedema with C1-inhibitor (C1-INH) deficiency (C1-INH-HAE). However, there are patients with C1-INH-HAE presenting with normal C4…
read more here.
Keywords:
total antigenic;
hae patients;
non functional;
hae ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Current problems in cancer"
DOI: 10.1016/j.currproblcancer.2022.100847
Abstract: Fibrolamellar hepatocellular carcinoma is a rare type of hepatocellular carcinoma with unclear etiology. Its prevalence ranges from 0.6%-5%. One of the rare manifestations of FHCC includes hyperammonemic hepatic encephalopathy (HAE). Data regarding HAE in FHCC…
read more here.
Keywords:
fibrolamellar hepatocellular;
hepatocellular carcinoma;
literature review;
carcinoma ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "International immunopharmacology"
DOI: 10.1016/j.intimp.2020.106293
Abstract: BACKGROUND Hereditary angioedema (HAE) with C1-inhibitor deficiency (C1-INH-HAE) is characterized by recurrent episodes of subcutaneous/submucosal edema, which may be preceded by erythema marginatum (EM) as a prodromal symptom. Our aim was to analyze the changes…
read more here.
Keywords:
erythema marginatum;
symptom free;
hae attacks;
hereditary angioedema ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "International immunopharmacology"
DOI: 10.1016/j.intimp.2020.106526
Abstract: Hereditary Angioedema (HAE) is a rare, autosomal dominant disease caused by mutations in SERPING1 gene leading to dysfunction/deficiency of C1-esterase inhibitor (C1-INH) protein and subsequent dysregulation of the contact system and bradykinin overproduction. As functional…
read more here.
Keywords:
point care;
plasma;
fc1 inh;
hae ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2018.1476851
Abstract: ABSTRACT Introduction: Hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE) is a rare disorder with life-threatening complications if untreated. It begins during childhood, and reduces the patient’s quality of life. Therefore, the availability of an…
read more here.
Keywords:
aged years;
treatment;
hereditary angioedema;
inhibitor deficiency ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2018.1503055
Abstract: ABSTRACT Introduction: Hereditary angioedema (HAE) due to C1 inhibitor (C1-INH) deficiency is a debilitating and potentially lethal disease. Management includes on-demand treatment of angioedema and their prophylaxis. Plasma derived C1-INH is an established treatment for…
read more here.
Keywords:
treatment;
prophylaxis;
conestat alfa;
rhc1 inh ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of tropical pediatrics"
DOI: 10.1093/tropej/fmac058
Abstract: OBJECTIVE Hereditary angioedema (HAE) is clinically characterized by recurrent attacks of angioedema. This study evaluated the clinical findings and examination results of patients admitted due to angioedema who then underwent a diagnostic test for HAE.…
read more here.
Keywords:
hae;
hereditary angioedema;
angioedema;
underwent diagnostic ... See more keywords